Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Mereo BioPharma Group plc | 66,000 | reported | 26 Feb 2026 | tx 16+271,244−278,244 |
| Theravance Biopharma, Inc. | 58,065 | reported | 19 May 2025 | tx 13+178,943 |
| Karyopharm Therapeutics Inc. | 15,508 | reported | 21 May 2026 | tx 48+2,559,314−4,053,639 |
| ALDER BIOPHARMACEUTICALS INC | 15,000 | reported | 23 May 2018 | tx 12+2,889,882−2,488,532 |
| OncoMed Pharmaceuticals Inc | 0 | reported | 23 Apr 2019 | tx 19+2,085,542−3,558,528 |
| TANDEM DIABETES CARE INC | 0 | reported | 19 Nov 2013 | tx 6+3,668,019−6,146,134 |
| Alexza Pharmaceuticals Inc. | 0 | reported | 21 Jun 2016 | tx 30+1,183,374−5,618,417 |
| Calithera Biosciences, Inc. | 0 | reported | 27 Jan 2023 | tx 22+4,468,404−121,333 |
| FS Development Corp. II | 0 | reported | 23 Dec 2021 | tx 4+82,500−82,500 |
1 purchase reported after at least 12 months of silence — most recent on 23 Jul 2013.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 15,508 | 0.00 USD | |
| 26 Feb 2026 | GRANT_AWARD | Mereo BioPharma Group plc | 66,000 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 4,600 | 0.00 USD | deriv |
| 19 May 2025 | GRANT_AWARD | Theravance Biopharma, Inc. | 10,649 | 0.00 USD | |
| 19 May 2025 | GRANT_AWARD | Theravance Biopharma, Inc. | 24,258 | 0.00 USD | deriv |
| 05 Feb 2025 | GRANT_AWARD | Mereo BioPharma Group plc | 55,000 | 0.00 USD | deriv |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 43,485 | 0.94 USD | |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 2,071 | 3.87 USD | |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 12,418 | 2.72 USD | |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 38,953 | 1.31 USD | |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 6,492 | 1.84 USD | |
| 22 Aug 2024 | SALE | Mereo BioPharma Group plc | 105,244 | 4.43 USD | |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 1,825 | 3.00 USD | |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 55,000 | 0.00 USD | deriv |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 15,000 | 0.00 USD | deriv |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 55,000 | 0.00 USD | deriv |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 31,500 | 0.00 USD | deriv |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 5,500 | 0.00 USD | deriv |
| 22 Aug 2024 | EXERCISE | Mereo BioPharma Group plc | 11,000 | 0.00 USD | deriv |
| 05 Jun 2024 | SALE | Karyopharm Therapeutics Inc. | 463,518 | 0.96 USD | |
| 05 Jun 2024 | SALE | Karyopharm Therapeutics Inc. | 4,526 | 0.96 USD | |
| 07 Jun 2024 | SALE | Karyopharm Therapeutics Inc. | 2,240 | 0.95 USD | |
| 06 Jun 2024 | SALE | Karyopharm Therapeutics Inc. | 1,145 | 0.98 USD | |
| 07 Jun 2024 | SALE | Karyopharm Therapeutics Inc. | 229,308 | 0.95 USD | |
| 06 Jun 2024 | SALE | Karyopharm Therapeutics Inc. | 117,307 | 0.98 USD |